Source: Pharmaceutical Business Review

ABC Laboratories: EAG unveils further investments to improve ABC Laboratories' biopharmaceutical characterization capabilities

EAG has unveiled a major investment in ABC Laboratories' capacity and analytical capabilities to meet the pharmaceutical industry's need for high-end biopharmaceutical analysis.

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
100-250
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100

Read more